Topchoice Medical Co., Inc. (SHA:600763)

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Intersegment elimination	-229.11M	-213.86M	-174.96M	-204.21M	-
Sales Products	231.11M	133.38M	167.34M	192.28M	125.28M
Sales Products Growth	73.27%	-20.29%	-12.97%	53.48%	69.83%
Management Services and Others	126.63M	194.70M	145.06M	137.99M	785.95K
Management Services and Others Growth	-34.96%	34.22%	5.12%	17457.26%	134.86%
Medical Services	2.78B	2.76B	2.71B	2.59B	2.63B
Medical Services Growth	0.90%	1.86%	4.49%	-1.51%	31.06%
Total	2.91B	2.87B	2.85B	2.72B	2.76B
Total Growth	1.37%	0.96%	4.70%	-1.45%	32.45%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
China	2.91B	2.87B	2.85B	2.72B	2.78B
China Growth	1.37%	0.96%	4.70%	-2.23%	33.19%
Total	2.91B	2.87B	2.85B	2.72B	2.78B
Total Growth	1.37%	0.96%	4.70%	-2.23%	33.19%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 19, 2026

Data Sources Report a data error